ST Pharm's Family

Beyond the Limits and Fly High
Walking Together with ST PHARM
Gene therapy CDMO from oligonucleotide to xRNA
Seamless development from manufacturing to non-clinical animal safety service

ST Pharm

ST Pharm

South Korea

  • Seoul Office, Sihwa & Banwol Campus
  • CDMO service (Small molecule, Oligonucleotide, mRNA))
  • R&D (Vaccines, New drugs, etc.)

T+82 031 310 1100

Anapath Services (CRO)

Anapath Services

Basel, Switzerland

  • Histopathology service

T+41 61 906 40 00 Einfo@anapath.ch

AnaPath Research (CRO)

AnaPath Research

Barcelona, Spain

  • Non-clinical animal safety assessment

T+34 93 719 03 61 Einfo@anapathresearch.com

LEVATIO

LEVATIO

San Diego, USA

  • Platform-based biotech
    (mRNA, CAR-NKT, circ-RNA, etc.)

Eadmin@levatiotherapeutics.com

STP America Research

STP America Research

Delaware, USA

  • USA Headquarters of ST Pharm
  • A liaison office for connections between global R&D institutions and academies

VERNAGEN

VERNAGEN

Atlanta, USA

  • mRNA Vaccines & Therapeutics-based biotech

ST Pharm's Facilities

Beyond the Limits and Fly High
Walking Together with ST PHARM
Sihwa Campus
Sihwa Campus

R&D Center
QA / QC

Main Office
(Cafeteria, etc.)

Plant 6

Oligo Plant
(Pilot scale)

Banwol Campus
Banwol Campus

Oligo the 1st Plant
(Commercial scale)

Innovation Center
(R&D Center)

Main Office
(Cafeteria, etc.)

mRNA Plant

Synthetic Plant C

Synthetic Plant B

Synthetic Plant A

the 2nd Oligo Plant

General Capacity

General Capacity
Sihwa
Banwol
Total
Area (m2)
16,400
28,220
44,620
Reactors
67
58
125
Capcity (L)
286,100
139,000
425,100

Small Molecule

Small Molecule
Sihwa
Banwol
Commercial Plant (L)
3,000 – 7,000
3,000 – 7,000
Kilo/Pilot Plant (L)

Kilo: 50 – 100

Pilot: 200 – 500

Kilo: 100

Sector 3/4: 500 – 2,000

Oligo Plants

Oligo Plants
Sihwa
Banwol
Note
Small scale
0.016 mole scale
Mid scale
0.4 mole scale
Large scale
(300 mmol scale): 2 x AKB
(1.5 mole scale): 1 x GE
above (4.6 mole scale):
in 2022

* Oligo Capacity : 3.5 x the current capacity, Global No.1 (6.4mol, in 2022)